High VEGFC expression is associated with unique gene expression profiles and predicts adverse prognosis in pediatric and adult acute myeloid leukemia
Hendrik J.M. de Jonge(University Medical Center Groningen), Eveline S.J.M. de Bont(Hôpital Saint-Michel), Monique L. den Boer(Princess Máxima Center), Marry M. van den Heuvel‐Eibrink(Princess Máxima Center), Gertjan J.L. Kaspers(Emma Kinderziekenhuis), Nic J.G.M. Veeger(University Medical Center Groningen), Bob Löwenberg(Unknown), C. Michel Zwaan(Princess Máxima Center), Jacqueline Cloos(Vrije Universiteit Amsterdam), Peter J.M. Valk(Erasmus MC Cancer Institute), Válerie de Haas(Princess Máxima Center), Willem A. Kamps(Pediatric Oncology Group), Arja ter Elst(University Medical Center Groningen)
Cited by 109
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k